187 related articles for article (PubMed ID: 27218243)
1. Usefulness of daily surveillance blood cultures in allogeneic hematopoietic stem cell transplant recipients on steroids: a 1-year prospective study.
Colombier MA; Lafaurie M; de Fontbrune FS; Resche-Rigon M; Donay JL; Pons JL; Molina JM; Socie G
Transpl Infect Dis; 2016 Aug; 18(4):504-11. PubMed ID: 27218243
[TBL] [Abstract][Full Text] [Related]
2. Limited Utility of Outpatient Surveillance Blood Cultures in Hematopoietic Cell Transplant Recipients on High-Dose Steroids for Treatment of Acute Graft-versus-Host-Disease.
Stohs E; Chow VA; Liu C; Bourassa L; Miles-Jay A; Knight J; Sweet A; Storer BE; Mielcarek M; Pergam SA
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1247-1252. PubMed ID: 30711778
[TBL] [Abstract][Full Text] [Related]
3. Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center.
Nesher L; Chemaly RF; Shah DP; Mulanovich VE; Hosing C; Rolston KV
Am J Infect Control; 2014 Oct; 42(10):1084-8. PubMed ID: 25278398
[TBL] [Abstract][Full Text] [Related]
4. Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations.
Cohen SA; Woodfield MC; Boyle N; Stednick Z; Boeckh M; Pergam SA
Transpl Infect Dis; 2016 Oct; 18(5):699-705. PubMed ID: 27501401
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
[TBL] [Abstract][Full Text] [Related]
6. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
7. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
[TBL] [Abstract][Full Text] [Related]
8. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
9. Value of surveillance blood culture for early diagnosis of occult bacteremia in patients on corticosteroid therapy following allogeneic hematopoietic stem cell transplantation.
Chizuka A; Kami M; Kanda Y; Murashige N; Kishi Y; Hamaki T; Kim SW; Hori A; Kojima R; Mori SI; Tanosaki R; Gomi H; Takaue Y
Bone Marrow Transplant; 2005 Mar; 35(6):577-82. PubMed ID: 15665840
[TBL] [Abstract][Full Text] [Related]
10. Acute gastrointestinal graft-vs-host disease is associated with increased enteric bacterial bloodstream infection density in pediatric allogeneic hematopoietic cell transplant recipients.
Levinson A; Pinkney K; Jin Z; Bhatia M; Kung AL; Foca MD; George D; Garvin JH; Sosna J; Karamehmet E; Robinson C; Satwani P
Clin Infect Dis; 2015 Aug; 61(3):350-7. PubMed ID: 25948061
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients.
Mikulska M; Del Bono V; Prinapori R; Boni L; Raiola AM; Gualandi F; Van Lint MT; Dominietto A; Lamparelli T; Cappellano P; Bacigalupo A; Viscoli C
Transpl Infect Dis; 2010 Dec; 12(6):505-12. PubMed ID: 20636482
[TBL] [Abstract][Full Text] [Related]
12. Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.
Hong J; Moon SM; Ahn HK; Sym SJ; Park YS; Park J; Cho YK; Cho EK; Shin DB; Lee JH
Biol Blood Marrow Transplant; 2013 Jun; 19(6):994-9. PubMed ID: 23571460
[TBL] [Abstract][Full Text] [Related]
13. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Ali N; Adil SN; Shaikh MU
Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
[TBL] [Abstract][Full Text] [Related]
14. High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation.
Kameda K; Kimura SI; Akahoshi Y; Nakano H; Harada N; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Nakasone H; Kikuchi M; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
Biol Blood Marrow Transplant; 2016 Feb; 22(2):371-377. PubMed ID: 26415560
[TBL] [Abstract][Full Text] [Related]
15. Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance.
Mikulska M; Del Bono V; Raiola AM; Bruno B; Gualandi F; Occhini D; di Grazia C; Frassoni F; Bacigalupo A; Viscoli C
Biol Blood Marrow Transplant; 2009 Jan; 15(1):47-53. PubMed ID: 19135942
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.
Gjaerde LI; Moser C; Sengeløv H
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28561378
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Hefazi M; Damlaj M; Alkhateeb HB; Partain DK; Patel R; Razonable RR; Gastineau DA; Al-Kali A; Hashmi SK; Hogan WJ; Litzow MR; Patnaik MM
Transpl Infect Dis; 2016 Dec; 18(6):913-920. PubMed ID: 27642723
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of risk factors for vancomycin-resistant Enterococcus bacteremia among previously colonized hematopoietic stem cell transplant patients.
Kang Y; Vicente M; Parsad S; Brielmeier B; Pisano J; Landon E; Pettit NN
Transpl Infect Dis; 2013 Oct; 15(5):466-73. PubMed ID: 23911080
[TBL] [Abstract][Full Text] [Related]
19. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients.
Mikulska M; Del Bono V; Bruzzi P; Raiola AM; Gualandi F; Van Lint MT; Bacigalupo A; Viscoli C
Infection; 2012 Jun; 40(3):271-8. PubMed ID: 22187340
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005.
Youssef S; Rodriguez G; Rolston KV; Champlin RE; Raad II; Safdar A
Medicine (Baltimore); 2007 Mar; 86(2):69-77. PubMed ID: 17435587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
